Serine/threonine-protein kinase AKT Inhibitors (IC50, Ki)

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	Staurosporine	IC50	11.0 [1]
	Akt inhibitor VIII	IC50	58.0 [1]
	(2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine	IC50	2.0 [1]
	(2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine	Ki	2.0 [1]
	Gsk-690693	IC50	2.0 [1]
	Gsk-690693	Ki	1.0 [1]
	2-[4-[2-(2-Aminopyridin-3-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]-N-phenylacetamide	IC50	2500.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)-6-cyclopentylimidazo[4,5-b]pyridin-3-yl]phenyl]methyl]benzamide	IC50	2100.0 [1]
	N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	IC50	1800.0 [1]
	N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	Ki	4500.0 [1]
	N-[[4-[5-(3-Acetamidophenyl)-2-(2-aminopyridin-3-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methyl]-3-fluorobenzamide	IC50	44.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methyl]benzamide	IC50	5600.0 [1]
	2-[4-[5-(3-Acetamidophenyl)-2-(2-aminopyridin-3-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]-N-phenylacetamide	IC50	49.0 [1]
	2-[4-[2-(2-Aminopyridin-3-yl)-5-pyridin-3-ylimidazo[4,5-b]pyridin-3-yl]phenyl]-N-phenylacetamide	IC50	65.0 [1]
	N-[[4-[5-(3-Acetamidophenyl)-2-(2-aminopyridin-3-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methyl]benzamide	IC50	140.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)-5-pyridin-3-ylimidazo[4,5-b]pyridin-3-yl]phenyl]methyl]benzamide	IC50	740.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)-6-pyridin-3-ylimidazo[4,5-b]pyridin-3-yl]phenyl]methyl]benzamide	IC50	91.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)-6-bromoimidazo[4,5-b]pyridin-3-yl]phenyl]methyl]benzamide	IC50	2500.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)-5-phenylimidazo[4,5-b]pyridin-3-yl]phenyl]methyl]benzamide	IC50	410.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)-6-phenylimidazo[4,5-b]pyridin-3-yl]phenyl]methyl]benzamide	IC50	680.0 [1]
	2-[4-[5-(3-Acetamidophenyl)-2-(2-aminopyridin-3-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]-N-(3-fluorophenyl)acetamide	IC50	120.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)-5-pyridin-3-ylimidazo[4,5-b]pyridin-3-yl]phenyl]methyl]-3-fluorobenzamide	IC50	340.0 [1]
	N-[[4-[2-(2-Aminopyridin-3-yl)-6-pyridin-3-ylimidazo[4,5-b]pyridin-3-yl]phenyl]methyl]-3-fluorobenzamide	IC50	54.0 [1]
	(2S)-1-N-(5-Isoquinolin-6-yl-1,3,4-thiadiazol-2-yl)-3-[4-(trifluoromethyl)phenyl]propane-1,2-diamine	IC50	247.0 [1]
	(2s)-1-(1h-Indol-3-Yl)-3-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}propan-2-Amine	IC50	0.16 [1], 2.5 [2]
	(2s)-1-(1h-Indol-3-Yl)-3-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}propan-2-Amine	Ki	0.16 [1]
	Medermycin	IC50	149.0 [1], 30400.0 [2], 38500.0 [3]
	2-[4-(3-Phenylquinoxalin-2-yl)phenyl]propan-2-amine	IC50	3400.0 [1], 250000.0 [2]
	(1S)-2-(1H-Indol-3-YL)-1-[({5-[(E)-2-pyridin-4-ylvinyl]pyridin-3-YL}oxy)methyl]ethylamine	IC50	14.0 [1], 360.0 [2], 3000.0 [3]
	A-674563	IC50	14.0 [1], 125.0 [2], 100000.0 [3]
	A-674563	Ki	11.0 [1]
	Merck-22-6	IC50	138.0 [1], 253.0 [2], 527.0 [3]
	3-[1-[[4-(5-Methyl-6-oxo-2-phenyl-1H-pyrazin-3-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one	IC50	760.0 [1]
	3-[1-[[4-(5-Methyl-6-oxo-2-phenyl-1H-pyrazin-3-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one	Ki	760.0 [1]
	1-(1-{[4-(3-Phenylquinoxalin-2-yl)phenyl]methyl}piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one	IC50	290.0 [1], 295.0 [2]
	4-Amino-n-(1,3,4-thiadiazol-2-yl)benzenesulfonamide	IC50	20000.0 [1], 25000.0 [2]
	4-Amino-n-(1,3,4-thiadiazol-2-yl)benzenesulfonamide	Ki	50000.0 [1]
	6-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]-2-chloropyridin-3-yl}isoquinoline	IC50	1.8 [1], 3000.0 [2], 5700.0 [3]
	7-[4-[[4-(4-Aminopyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl]methyl]phenyl]-6-phenylpyrido[2,3-d]pyrimidin-4-amine	IC50	14.0 [1], 295.0 [2]
	N,N-Dimethyl-2-[4-[6-phenyl-7-[4-[[4-(3-pyridin-2-yl-1H-1,2,4-triazol-5-yl)piperidin-1-yl]methyl]phenyl]pyrido[2,3-d]pyrimidin-2-yl]piperazin-1-yl]ethanamine	IC50	4.0 [1], 10.0 [2]
	N-Methyl-6-phenyl-7-[4-[[4-(3-pyridin-2-yl-1H-1,2,4-triazol-5-yl)piperidin-1-yl]methyl]phenyl]pyrido[2,3-d]pyrimidin-2-amine	IC50	6.0 [1], 20.0 [2], 20.3 [3]
	7-[4-[[4-(6-Fluoro-1H-benzimidazol-2-yl)piperidin-1-yl]methyl]phenyl]-6-phenylpyrido[2,3-d]pyrimidin-4-amine	IC50	18.0 [1], 277.0 [2]
	6-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}isoquinolin-3-amine	IC50	3.4 [1], 200.0 [2], 930.0 [3]
	Pictilisib	IC50	28.0 [1], 37.0 [2], 46.0 [3]
	Frenolicin B	IC50	198.0 [1], 313.0 [2]
	4-Dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide	IC50	6300.0 [1], 10000.0 [2]
	4-Dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide	Ki	2400.0 [1]
	(S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol	IC50	10.0 [1], 38.0 [2], 1100.0 [3]
	(11R,15R,17R)-17-Methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione	IC50	150.0 [1], 280.0 [2]
	3-[4-[[4-(2-Oxo-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]phenyl]-2-phenylquinoxaline-6-carboxylic acid	IC50	166.0 [1]
	3-[(2S)-2-Amino-3-phenylpropoxy]-5-[(E)-2-(pyridin-4-yl)ethenyl]pyridine	IC50	690.0 [1]
	2-[4-[[4-(2-Oxo-3H-benzimidazol-1-yl)piperidin-1-yl]methyl]phenyl]-3-phenylquinoxaline-6-carboxylic acid	IC50	240.0 [1]
	(2s)-1-{[6-Furan-3-Yl-5-(3-Methyl-2h-Indazol-5-Yl)pyridin-3-Yl]oxy}-3-(1h-Indol-3-Yl)propan-2-Amine	IC50	1.0 [1], 500.0 [2]
	(2R)-2-Amino-3-(4-fluorophenyl)-1-[4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazin-1-yl]propan-1-one	IC50	3.0 [1], 160.0 [2]
	1-(2-Aminophenyl)-3-[[4-(2-methylsulfanyl-6-phenylpyrido[2,3-d]pyrimidin-7-yl)phenyl]methylamino]propan-1-one	IC50	15.0 [1], 78.0 [2]
	4-Spiro[2H-indole-3,4'-piperidine]-1-yl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile	IC50	2.0 [1], 2.4 [2], 50.0 [3]
	9-Phenyl-8-[4-[[4-(3-pyridin-2-yl-1H-1,2,4-triazol-5-yl)piperidin-1-yl]methyl]phenyl]-[1,2,4]triazolo[3,4-f][1,6]naphthyridine	IC50	4.0 [1], 5.0 [2]
	6-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}-3-fluoroisoquinoline	IC50	3.5 [1], 2300.0 [2]
	4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3R)-piperidin-3-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol	IC50	2.0 [1], 3.0 [2], 400.0 [3]
	N-(4-(N-1,3,4-Thiadiazol-2-ylsulfamoyl)phenyl)decanamide	IC50	10000.0 [1], 15000.0 [2]
	N-(4-(N-1,3,4-Thiadiazol-2-ylsulfamoyl)phenyl)decanamide	Ki	21800.0 [1]
	N-(4-(N-1,3,4-Thiadiazol-2-ylsulfamoyl)phenyl)-2-(2-(2-methoxyethoxy)ethoxy)acetamide	IC50	50000.0 [1]
	N-(4-(N-1,3,4-Thiadiazol-2-ylsulfamoyl)phenyl)-2-(2-(2-methoxyethoxy)ethoxy)acetamide	Ki	50000.0 [1]
	N-[5-Chloro-3-[4-(3-ethyl-2H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenyl]-N',N'-dimethylethane-1,2-diamine	IC50	371.0 [1], 9026.0 [2]
	N-[3-[4-(3-Bromo-2H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-2-methylphenyl]-N',N'-dimethylethane-1,2-diamine	IC50	53.0 [1], 4285.0 [2]
	N-(4-(N-1,3,4-Thiadiazol-2-ylsulfamoyl)phenyl)acetamide	IC50	50000.0 [1]
	N-(4-(N-1,3,4-Thiadiazol-2-ylsulfamoyl)phenyl)acetamide	Ki	50000.0 [1]
	(2S)-1-N-[5-(3-Methyl-2H-indazol-5-yl)-1,3,4-thiadiazol-2-yl]-3-[4-(trifluoromethyl)phenyl]propane-1,2-diamine	IC50	5.5 [1], 333.0 [2], 357.0 [3]
	(2S)-1-N-[5-(1H-Indazol-5-yl)-1,3,4-thiadiazol-2-yl]-3-[4-(trifluoromethyl)phenyl]propane-1,2-diamine	IC50	6.0 [1], 154.0 [2], 444.0 [3]
	MK-2206	IC50	8.0 [1], 10.0 [2]
	Capivasertib	IC50	3.0 [1], 34.0 [2]
	Ipatasertib	IC50	5.0 [1], 157.0 [2]
	4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine	IC50	0.66 [1], 3.0 [2]
	Uprosertib	IC50	2.0 [1], 18.0 [2]
	N-[6-[6-Chloro-5-[[(4-fluorophenyl)sulfonyl]amino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide	IC50	6.3 [1]
	(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one	IC50	4500.0 [1]
	(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one	Ki	3900.0 [1]
	(S)-2-(2-(2-Methylindolin-1-yl)-2-oxoethyl)-6-morpholinopyrimidin-4(3H)-one	IC50	9.0 [1], 12.0 [2]
	(Z)-3-((1H-Pyrrol-2-yl)methylene)indolin-2-one	IC50	2300.0 [1], 3000.0 [2]
	(1S)-1-Methyl-2-[5-[2-(4-pyridyl)vinyl]-6-chloro-3-pyridyloxy]ethanamine	IC50	5290.0 [1]
	[(2R)-2-Methoxy-3-octadecoxypropyl] [(1R,2S,3S,4R,6R)-2,3,4,6-tetrahydroxycyclohexyl] hydrogen phosphate	IC50	1500.0 [1]
	5-[5-[(1,3-Dioxoindan-2-ylidene)methyl]-2-furyl]-2-hydroxy-benzoic acid	IC50	25100.0 [1]
	5-[5-[(1,3-Dioxoindan-2-ylidene)methyl]-2-furyl]-2-hydroxy-benzoic acid	Ki	20800.0 [1]
	3-(4'-Hydroxybiphenyl-4-Yl)-N-(4-Hydroxycyclohexyl)-1,4-Dihydroindeno[1,2-C]pyrazole-6-Carboxamide	IC50	4430.0 [1]
	AKT Kinase Inhibitor	IC50	2.0 [1], 1130.0 [2]
	Akt inhibitor	IC50	0.5 [1], 310.0 [2]
	3-(3-Iodobenzyl)-1-tert-butyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	IC50	28.0 [1], 10000.0 [2]
	[(2R)-2-Methoxy-3-octadecoxypropyl] [(1R,2S,3S,4R,5S,6R)-2,3,4,6-tetrahydroxy-5-(hydroxymethyl)cyclohexyl] carbonate	IC50	5000.0 [1], 32000.0 [2]
	5-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}-1H-indazole	IC50	1.5 [1]
	N-[4-[5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl]phenyl]acetamide	IC50	227.0 [1]
	6-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]-6-chloropyridin-3-yl}isoquinoline	IC50	12.0 [1]
	(E)-3-(4-Bromophenyl)-N-[2-[5-[(E)-2-pyridin-4-ylethenyl]pyridin-3-yl]oxyethyl]prop-2-en-1-amine	IC50	32250.0 [1]
	3-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]-6-(pyridin-4-yl)quinoline	IC50	300.0 [1]
	3-[1-[[4-(6-Oxo-2-phenyl-1H-pyrazin-3-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one	IC50	3029.0 [1]
	3-[1-[[4-[5-(2-Methylpropyl)-6-oxo-3-phenyl-1H-pyrazin-2-yl]phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one	IC50	20000.0 [1], 21200.0 [2]
	(2S)-2-Amino-3-(1H-indol-3-yl)-N-[5-[(E)-2-pyridin-4-ylethenyl]pyridin-3-yl]propanamide	IC50	278.0 [1]
	5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]-N-pyridin-4-ylpyridine-3-carboxamide	IC50	1659.0 [1], 2020.0 [2]
	3-N-[(2S)-2-Amino-3-(1H-indol-3-yl)propyl]-5-N-isoquinolin-5-ylpyridine-3,5-diamine	IC50	270.0 [1]
	(2S)-3-(1H-Indol-3-yl)-1-N-(5-isoquinolin-5-yloxypyridin-3-yl)propane-1,2-diamine	IC50	210.0 [1]
	3-[1-[[4-(6-Oxo-3-phenyl-1H-pyrazin-2-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one	IC50	1500.0 [1]

Entire TableStructureCompound NameStandard TypeStandard Values (in nM)

Items per page: 510All1 - 10 of 100 ⟨⟩

---

---

References

This online tool may be cited as follows

MLA	"Quest Database™ Serine/threonine-protein kinase AKT Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 9 May. 2024, https://www.aatbio.com/data-sets/serine-threonine-protein-kinase-akt-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2024, May 9). Quest Database™ Serine/threonine-protein kinase AKT Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/serine-threonine-protein-kinase-akt-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan